Cross sectional analyses indicated that body fat distribution was not associated with performance-based and self-reported outcomes among ambulatory people with multiple sclerosis
Ariel Kidwell-Chandler, Brenda Jeng, Robert W. Motl
{"title":"Cross sectional analyses indicated that body fat distribution was not associated with performance-based and self-reported outcomes among ambulatory people with multiple sclerosis","authors":"Ariel Kidwell-Chandler, Brenda Jeng, Robert W. Motl","doi":"10.1016/j.msard.2026.107084","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Obesity is cited as a relevant factor in multiple sclerosis (MS). To date, there is inconsistent evidence regarding the relationship between total body fat and frequently studied outcomes in MS. Body fat distribution, or the location of adipose tissue and depots within the body, may represent a biologically meaningful correlate of MS-related outcomes.</div></div><div><h3>Purpose</h3><div>This exploratory study assessed whether dual-energy X-ray absorptiometry (DXA)-based body fat distribution metrics were associated with performance-based and self-reported outcomes of MS.</div></div><div><h3>Methods</h3><div>Fifty-seven ambulatory adults with MS underwent DXA to quantify visceral and subcutaneous adipose tissue; android- and gynoid- % fat mass; and android/gynoid ratio. Outcomes included performance-based (Timed Up and Go, Timed 25-Foot Walk, Six-Minute Walk) and self-reported assessments (Hospital Anxiety and Depression Scale anxiety and depression [HADS-D] sub-scales), Multiple Sclerosis Impact Scale physical [MSIS Physical] and psychological domains, Fatigue Severity Scale, and the short form of the McGill Pain Questionnaire). Spearman correlation assessed bivariate and partial (controlling for sex and age) associations.</div></div><div><h3>Results</h3><div>Correlations between body fat distribution metrics and performance-based and self-reported outcomes were generally small and not statistically significant. Gynoid % fat mass correlated with depressive symptoms (HADS-D: <em>r<sub>s</sub></em> = –.28, <em>p</em> = .033) and physical health-related quality of life (MSIS Physical: <em>r<sub>s</sub></em> = –.31, <em>p</em> = .018), but partial correlations were not statistically significant.</div></div><div><h3>Conclusion</h3><div>Our results did not support an association between body fat distribution and frequently studied MS-related outcomes. This aligns with research suggesting a limited role of adiposity and MS-related outcomes.</div></div>","PeriodicalId":18958,"journal":{"name":"Multiple sclerosis and related disorders","volume":"109 ","pages":"Article 107084"},"PeriodicalIF":3.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis and related disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211034826001203","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Obesity is cited as a relevant factor in multiple sclerosis (MS). To date, there is inconsistent evidence regarding the relationship between total body fat and frequently studied outcomes in MS. Body fat distribution, or the location of adipose tissue and depots within the body, may represent a biologically meaningful correlate of MS-related outcomes.
Purpose
This exploratory study assessed whether dual-energy X-ray absorptiometry (DXA)-based body fat distribution metrics were associated with performance-based and self-reported outcomes of MS.
Methods
Fifty-seven ambulatory adults with MS underwent DXA to quantify visceral and subcutaneous adipose tissue; android- and gynoid- % fat mass; and android/gynoid ratio. Outcomes included performance-based (Timed Up and Go, Timed 25-Foot Walk, Six-Minute Walk) and self-reported assessments (Hospital Anxiety and Depression Scale anxiety and depression [HADS-D] sub-scales), Multiple Sclerosis Impact Scale physical [MSIS Physical] and psychological domains, Fatigue Severity Scale, and the short form of the McGill Pain Questionnaire). Spearman correlation assessed bivariate and partial (controlling for sex and age) associations.
Results
Correlations between body fat distribution metrics and performance-based and self-reported outcomes were generally small and not statistically significant. Gynoid % fat mass correlated with depressive symptoms (HADS-D: rs = –.28, p = .033) and physical health-related quality of life (MSIS Physical: rs = –.31, p = .018), but partial correlations were not statistically significant.
Conclusion
Our results did not support an association between body fat distribution and frequently studied MS-related outcomes. This aligns with research suggesting a limited role of adiposity and MS-related outcomes.
期刊介绍:
Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.
A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.